Does Oxaliplatin Improve Survival Over Cisplatin in Advanced Gastric Cancer?

Researchers tested the novel oral fluoropyrimidine derivative S-1 plus oxaliplatin vs S-1 plus cisplatin in patients with diffuse-type or mixed-type advanced gastric adenocarcinoma.

Source: CancerNetwork - June 3, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news